Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

So far, SARS-CoV-2 is the seventh coronavirus found to infect humans and cause disease with quite a strong infectivity. Patients diagnosed as severe or critical cases are prone to multiple organ dysfunction syndrome, acute respiratory distress syndrome and even death. Proinflammatory cytokine IL-6 has been reported to be associated with the severity of disease and mortality in patients with COVID-19.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Postgrad Med J

Title: Postgraduate medical journal

Publisher: BMJ

ISSN (Electronic): 1469-0756

ISSN (Print): 0032-5473

Publication date (Electronic): Nov 01 2022

Volume: 98

Issue: 1165

Affiliations

[1 ] The Respiratory Department, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Article

Publisher Item ID: 7097008

DOI: 10.1136/postgradmedj-2021-139939

PubMed ID: 37063032

SO-VID: 4163c08c-d8ad-4e27-b0ab-ae9a505e5faf

History

Keywords: toxicology,immunology

Data availability:

Keywords: toxicology, immunology

Comments

Comment on this article

scite_

Cited by 9

See all cited by